Quality of care in patients with psoriasis: an initial clinical study of an international disease management programme

Korte, J. de; Onselen, Julie Van; Kownacki, Stephen; Sprangers, Mirjam A. G.; Bos, Jurriaan

doi:10.1111/j.1468-3083.2004.01107.x

Cited by 47 publications

(58 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Twenty-four of them were retained after filtering duplicates. After reading the remaining articles in full, four were excluded because their intervention was mainly non-educational (10)(11)(12)(13), five on the grounds of absence of a QoL outcome parameter (14)(15)(16)(17)(18), and a further five because they turned out to be non-randomised studies (19)(20)(21)(22)(23). Searching the references used in a systematic review on atopic dermatitis by Errser et al (24) yielded one additional publication (25).…”

Section: Literature Searchmentioning

confidence: 98%

Patient Education in Chronic Skin Diseases: A Systematic Review

Bes¹,

Legierse²,

Prinsen³

et al. 2011

Acta Derm Venerol

View full text Add to dashboard Cite

The negative impact of skin disease on quality of life (QoL) has been described in many studies. Patient education as an adjunct to treatment, with the aim of improving QoL and reducing disease severity, is a relatively new technique in dermatology. The objective of this article is to analyse and summarise evidence concerning the effects of patient education on QoL and disease severity in patients with chronic skin diseases. All source material was identified through searches in MEDLINE and Embase. The CONSORT statement was used to assess the quality of reported randomised controlled studies. Ten of 254 studies met the inclusion criteria. In five of them, statistically significant improvements in QoL were reported. The severity of skin disease significantly improved in three studies. In conclusion, patient education appears to be effective in improving QoL and in reducing the perceived severity of skin disease.

show abstract

Section: Literature Searchmentioning

confidence: 98%

Patient Education in Chronic Skin Diseases: A Systematic Review

Bes¹,

Legierse²,

Prinsen³

et al. 2011

Acta Derm Venerol

View full text Add to dashboard Cite

show abstract

“…The management of psoriasis depends upon the cultural habits of each country, the health insurance system, the number of patients and physician demography [19,56,57,58,59,60]. In the French national context, the vast majority of patients stated that they had consulted a medical practitioner for their disease, and about 40% had seen a dermatologist, which represents a significant economic burden.…”

Section: Discussionmentioning

confidence: 99%

Psoriasis in France and Associated Risk Factors: Results of a Case-Control Study Based on a Large Community Survey

et al. 2008

View full text Add to dashboard Cite

Background: Risk factors for psoriasis have been identified. Objective: To precisely define these associated factors. Methods: A survey was conducted using a questionnaire on a representative sample of the French population. A case-control study was conducted. Cases were persons who declared having had psoriasis during the previous 12 months. For each case, 3 matched controls were selected. Cases and controls were compared using univariate and multivariate analyses. Results: The questionnaire was filled out and returned by 6,887 (68.9%) of 10,000 subjects aged 15 years and over; 356 cases were identified. In multivariate analysis, a higher body mass index, current and former smoking habits and β-blocker intake were independently associated with a higher risk of psoriasis; intake of statins was associated with a decreased risk (p < 0.05). Conclusions: We confirmed the association of overweight, smoking habits and β-blocker intake with psoriasis and reported a decreased risk associated with statin intake.

show abstract

“…Hopefully, less experienced dermatologists refer patients in need of these conventional but potentially toxic therapies to more experienced colleagues instead of denying patients these treatments. Although it may be less convenient for patients from a practical perspective, a recent European study suggested that the creation of subspecialized care centres for psoriasis increased satisfaction with care [21]. …”

Section: Discussionmentioning

confidence: 99%

Dermatologists’ Views and Opinions about Photo(chemo)therapy and Conventional Systemic Psoriasis Therapies: Results from a Belgian Survey

Nijsten

Lambert

2006

Dermatology

View full text Add to dashboard Cite

Background: Experts’ opinions about old and new psoriasis therapies are well documented. Objectives: To document the views and opinions of a large, diverse group of dermatologists about psoriasis treatment. Participants/Methods: A survey was conducted among Belgian dermatologists. In addition to demographic and professional characteristics, the questionnaire assessed the self-rated level of experience, frequency of use, preference and considerations regarding UVB, PUVA, methotrexate (MTX), cyclosporin (CsA) and acitretin. Multivariate logistic regression analyses were performed to investigate predictors of these dermatologist-based outcomes. Results: Of the 628 contacted dermatologists, 310 responded (response rate of 49.3%). The dermatologists were significantly more experienced with photo(chemo)therapy than with systemic agents (p ≤ 0.02); about half reported none or little experience with MTX and CsA. Also, photo(chemo)therapies were significantly more frequently used than systemic drugs (p ≤ 0.01). In the last year, almost 40% had not used and less than 10% had used MTX or CsA more than 10 times. Despite the limitations of PUVA, it was preferred to UVB, followed by acitretin (± phototherapy), and MTX and CsA were considered final options by most dermatologists. After adjusting for confounding variables, age, years in practice, seeing and treating more patients, residency programme and/or access to UV therapy were significantly associated with limited experience, regular use and/or preference of studied therapies. Conclusion: Either a substantial proportion of the dermatologists does not need or wish to use conventional systemic psoriasis therapies or they may need better and more uniform training during and after their residency. This may improve patient care and patient selection for other treatments.

show abstract

Quality of care in patients with psoriasis: an initial clinical study of an international disease management programme

Abstract: The disease management programme was found to be a useful tool in the management of psoriasis, providing patients with relief from the burden of psoriasis in everyday life. A full-scale evaluation is recommended.

Cited by 47 publications

References 15 publications

Patient Education in Chronic Skin Diseases: A Systematic Review

Patient Education in Chronic Skin Diseases: A Systematic Review

Psoriasis in France and Associated Risk Factors: Results of a Case-Control Study Based on a Large Community Survey

Dermatologists’ Views and Opinions about Photo(chemo)therapy and Conventional Systemic Psoriasis Therapies: Results from a Belgian Survey

Contact Info

Product

Resources

About